Basic Information
| RNALocate ID: | RLID:11002224 |
| RNA Symbol: | hsa-miR-155-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-155-5p |
| RNA ID: | miRBase:MIMAT0000646 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23382797 |
| Tissue/Cell Line: | Brain tissue |
| Method: | Microarray |
| Description: | We performed miRNA expression analysis using a FlexMAP3D instrument by (Luminex Corporation, Austin, TX) and a manufacturer's assay for 312 miRNA (Table S1). Data are collected from Table S1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001954 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001955 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:11002215 | Exosome | Cell lines (MCF10A|MCF-7|MDA-MB-231) | 25446899 |
| RLID:11002216 | Exosome | NBL cell lines (CHLA-255|IMR-32|SK-N-BE(2)) | 25972604 |
| RLID:11002217 | Exosome | Bronchoalveolar lavage fluid|Pooled sera | 27278097 |
| RLID:11002218 | Exosome | BC cell lines (HCC70|MCF-7|MDA-MB-231) | 30728048 |
| RLID:11002219 | Exosome | Serum | 18589210 |
| RLID:11002220 | Exosome | Plasma | 19289371 |
| RLID:11002221 | Exosome | Human embryonic kidney cell line (HEK-293) | 20353945 |
| RLID:11002222 | Exosome | Primary dendritic cells | 21505438 |
| RLID:11002223 | Exosome | Breast milk | 22211110 |
| RLID:11002225 | Exosome | Plasma | 23663360 |
| RLID:11002226 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11002227 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000106 | Exosome | B lymphoblastoid cells|Chronic lymphocytic leukemia cells|Endothelial cells|Lymphoma tissue|Seminal fluid | |
| RLID-D:11000393 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-155-5p | Cardiomyopathies | MNDR-E-MI-17720 |
| MNDR | hsa-miR-155-5p | Diffuse large b cell lymphoma | MNDR-E-MI-17721 |
| MNDR | hsa-miR-155-5p | Splenic marginal zone lymphoma | MNDR-E-MI-17722 |
| MNDR | hsa-miR-155-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-17723 |
| MNDR | hsa-miR-155-5p | Renal fibrosis | MNDR-E-MI-17724 |
| MNDR | hsa-miR-155-5p | Oral squamous cell carcinoma | MNDR-E-MI-17725 |
| MNDR | hsa-miR-155-5p | Follicular cleaved lymphoma | MNDR-E-MI-17726 |
| MNDR | hsa-miR-155-5p | Medulloblastoma | MNDR-E-MI-17727 |
| MNDR | hsa-miR-155-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-17728 |
| MNDR | hsa-miR-155-5p | Lymphoma | MNDR-E-MI-17729 |
| MNDR | hsa-miR-155-5p | Lymphoma non-hodgkin | MNDR-E-MI-17730 |
| MNDR | hsa-miR-155-5p | Cutaneous t cell lymphoma | MNDR-E-MI-17731 |
| MNDR | hsa-miR-155-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-17732 |
| MNDR | hsa-miR-155-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-17733 |
| MNDR | hsa-miR-155-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-17734 |
| MNDR | hsa-miR-155-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-17735 |
| MNDR | hsa-miR-155-5p | Her2-receptor positive breast cancer | MNDR-E-MI-17736 |
| MNDR | hsa-miR-155-5p | Breast cancer luminal | MNDR-E-MI-17737 |
| MNDR | hsa-miR-155-5p | Niemann-pick disease type c | MNDR-E-MI-17738 |
| MNDR | hsa-miR-155-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-17739 |
| MNDR | hsa-miR-155-5p | Colorectal carcinoma | MNDR-E-MI-17740 |
| MNDR | hsa-miR-155-5p | Dermatomyositis | MNDR-E-MI-17741 |
| MNDR | hsa-miR-155-5p | Prostate cancer | MNDR-E-MI-17742 |
| MNDR | hsa-miR-155-5p | Chronic lymphocytic leukemia | MNDR-E-MI-17743 |
| MNDR | hsa-miR-155-5p | Gastric cancer | MNDR-E-MI-17744 |
| MNDR | hsa-miR-155-5p | Pre-eclampsia | MNDR-E-MI-17745 |
| MNDR | hsa-miR-155-5p | Alzheimer disease | MNDR-E-MI-17746 |
| MNDR | hsa-miR-155-5p | Hypertension | MNDR-E-MI-17747 |
| MNDR | hsa-miR-155-5p | Urinary bladder cancer | MNDR-E-MI-17748 |
| MNDR | hsa-miR-155-5p | Trachoma | MNDR-E-MI-17749 |
| MNDR | hsa-miR-155-5p | Dysautonomia familial | MNDR-E-MI-17750 |
| MNDR | hsa-miR-155-5p | Muscular dystrophy duchenne | MNDR-E-MI-17751 |
| MNDR | hsa-miR-155-5p | Facioscapulohumeral muscular dystrophy | MNDR-E-MI-17752 |
| MNDR | hsa-miR-155-5p | Head and neck cancer | MNDR-E-MI-17753 |
| MNDR | hsa-miR-155-5p | Leukemia | MNDR-E-MI-17754 |
| MNDR | hsa-miR-155-5p | Friedreich ataxia | MNDR-E-MI-17755 |
| MNDR | hsa-miR-155-5p | Cardiovascular disease | MNDR-E-MI-17756 |
| MNDR | hsa-miR-155-5p | Miller fisher syndrome | MNDR-E-MI-17757 |
| MNDR | hsa-miR-155-5p | Dilated cardiomyopathy | MNDR-E-MI-17758 |
| MNDR | hsa-miR-155-5p | Focal segmental glomerulosclerosis | MNDR-E-MI-17759 |
| MNDR | hsa-miR-155-5p | Brain cancer | MNDR-E-MI-17760 |
| MNDR | hsa-miR-155-5p | Lung cancer | MNDR-E-MI-17761 |
| MNDR | hsa-miR-155-5p | Giant cell arteritis | MNDR-E-MI-17762 |
| MNDR | hsa-miR-155-5p | Kawasaki disease | MNDR-E-MI-17763 |
| MNDR | hsa-miR-155-5p | Tuberous sclerosis | MNDR-E-MI-17764 |
| MNDR | hsa-miR-155-5p | Endometrial cancer | MNDR-E-MI-17765 |
| MNDR | hsa-miR-155-5p | Malaria cerebral | MNDR-E-MI-17766 |
| MNDR | hsa-miR-155-5p | Down syndrome | MNDR-E-MI-17767 |
| MNDR | hsa-miR-155-5p | Parkinson disease | MNDR-E-MI-17768 |
| MNDR | hsa-miR-155-5p | Niemann-pick disease | MNDR-E-MI-17769 |
| MNDR | hsa-miR-155-5p | Basal-like breast cancer | MNDR-E-MI-17770 |
| MNDR | hsa-miR-155-5p | Cancer | MNDR-E-MI-17771 |
| MNDR | hsa-miR-155-5p | Coronary stenotic lesions | MNDR-E-MI-17772 |
| MNDR | hsa-miR-155-5p | Pituitary neoplasms | MNDR-E-MI-17773 |
| MNDR | hsa-miR-155-5p | Pancreatic cancer | MNDR-E-MI-17774 |
| MNDR | hsa-miR-155-5p | Hepatitis C | MNDR-E-MI-17775 |
| MNDR | hsa-miR-155-5p | Melanoma | MNDR-E-MI-17776 |
| MNDR | hsa-miR-155-5p | Atherosclerosis | MNDR-E-MI-17777 |
| MNDR | hsa-miR-155-5p | Rectum adenocarcinoma | MNDR-E-MI-17778 |
| MNDR | hsa-miR-155-5p | Hepatitis B | MNDR-E-MI-17779 |
| MNDR | hsa-miR-155-5p | Nephroblastoma | MNDR-E-MI-17780 |
| MNDR | hsa-miR-155-5p | Colon cancer | MNDR-E-MI-17781 |
| MNDR | hsa-miR-155-5p | Multiple sclerosis | MNDR-E-MI-17782 |
| MNDR | hsa-miR-155-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-17783 |
| MNDR | hsa-miR-155-5p | Thyroid adenomas | MNDR-E-MI-17784 |
| MNDR | hsa-miR-155-5p | Pulmonary tuberculosis | MNDR-E-MI-17785 |
| MNDR | hsa-miR-155-5p | Carcinoma ductal breast | MNDR-E-MI-17786 |
| MNDR | hsa-miR-155-5p | Glioblastoma | MNDR-E-MI-17787 |
| MNDR | hsa-miR-155-5p | Astrocytoma | MNDR-E-MI-17788 |
| MNDR | hsa-miR-155-5p | Glioma | MNDR-E-MI-17789 |
| MNDR | hsa-miR-155-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-17790 |
| MNDR | hsa-miR-155-5p | Oligodendroglioma | MNDR-E-MI-17791 |
| MNDR | hsa-miR-155-5p | Nemaline myopathy | MNDR-E-MI-17792 |
| MNDR | hsa-miR-155-5p | Central nervous system lymphoma | MNDR-E-MI-17793 |
| MNDR | hsa-miR-155-5p | Chordoma | MNDR-E-MI-17794 |
| MNDR | hsa-miR-155-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-17795 |
| MNDR | hsa-miR-155-5p | Epilepsy temporal lobe | MNDR-E-MI-17796 |
| MNDR | hsa-miR-155-5p | Osteosarcoma | MNDR-E-MI-17797 |
| MNDR | hsa-miR-155-5p | Liposarcoma | MNDR-E-MI-17798 |
| MNDR | hsa-miR-155-5p | Coronary artery disease | MNDR-E-MI-17799 |
| MNDR | hsa-miR-155-5p | Inclusion body myositis | MNDR-E-MI-17800 |
| MNDR | hsa-miR-155-5p | Breast carcinoma | MNDR-E-MI-17801 |
| MNDR | hsa-miR-155-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-17802 |
| MNDR | hsa-miR-155-5p | Meningioma | MNDR-E-MI-17803 |
| MNDR | hsa-miR-155-5p | Gastric adenocarcinoma | MNDR-E-MI-17804 |
| MNDR | hsa-miR-155-5p | Pituitary adenoma | MNDR-E-MI-17805 |
| MNDR | hsa-miR-155-5p | Lung squamous cell carcinoma | MNDR-E-MI-17806 |
| MNDR | hsa-miR-155-5p | Carcinoma lung non-small-cell | MNDR-E-MI-17807 |
| MNDR | hsa-miR-155-5p | Lung adenocarcinoma | MNDR-E-MI-17808 |
| MNDR | hsa-miR-155-5p | Acute myocarditis | MNDR-E-MI-17809 |
| MNDR | hsa-miR-155-5p | Thyroid carcinoma | MNDR-E-MI-17810 |
| MNDR | hsa-miR-155-5p | Papillary thyroid carcinoma | MNDR-E-MI-17811 |
| MNDR | hsa-miR-155-5p | Pancreatic adenocarcinoma | MNDR-E-MI-17812 |
| MNDR | hsa-miR-155-5p | Liver disease | MNDR-E-MI-17813 |
| MNDR | hsa-miR-155-5p | Scleroderma | MNDR-E-MI-17814 |
| MNDR | hsa-miR-155-5p | Cervical cancer | MNDR-E-MI-17815 |
| MNDR | hsa-miR-155-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-17816 |
| MNDR | hsa-miR-155-5p | Carcinoma renal cell | MNDR-E-MI-17817 |
| MNDR | hsa-miR-155-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-17818 |
| MNDR | hsa-miR-155-5p | Clear cell renal cell carcinoma | MNDR-E-MI-17819 |
| MNDR | hsa-miR-155-5p | Uremia | MNDR-E-MI-17820 |
| MNDR | hsa-miR-155-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-17821 |
| MNDR | hsa-miR-155-5p | Cholangiocarcinoma | MNDR-E-MI-17822 |
| MNDR | hsa-miR-155-5p | Esophageal cancer | MNDR-E-MI-17823 |
| MNDR | hsa-miR-155-5p | Chronic inflammatory demyelinating polyradiculoneuropathy | MNDR-E-MI-17824 |
| MNDR | hsa-miR-155-5p | HIV | MNDR-E-MI-17825 |
| MNDR | hsa-miR-155-5p | Stomach carcinoma | MNDR-E-MI-17826 |
| MNDR | hsa-miR-155-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-17827 |
| MNDR | hsa-miR-155-5p | Heart failure | MNDR-E-MI-17828 |
| MNDR | hsa-miR-155-5p | Adenoma | MNDR-E-MI-17829 |
| MNDR | hsa-miR-155-5p | Breast invasive carcinoma | MNDR-E-MI-17830 |
| MNDR | hsa-miR-155-5p | Juvenile rheumatoid arthritis | MNDR-E-MI-17831 |
| MNDR | hsa-miR-155-5p | Hepatocelluar carcinoma | MNDR-E-MI-17832 |
| MNDR | hsa-miR-155-5p | B-cell lymphoma | MNDR-E-MI-17833 |
| MNDR | hsa-miR-155-5p | Ankylosing spondylitis | MNDR-E-MI-17834 |
| MNDR | hsa-miR-155-5p | Rheumatoid arthritis | MNDR-E-MI-17835 |
| MNDR | hsa-miR-155-5p | T-cell leukemia | MNDR-E-MI-17836 |
| MNDR | hsa-miR-155-5p | Malignant pleural mesothelioma | MNDR-E-MI-17837 |
| MNDR | hsa-miR-155-5p | Chronic kidney disease | MNDR-E-MI-17838 |
| MNDR | hsa-miR-155-5p | Chronic myeloid leukemia | MNDR-E-MI-17839 |
| MNDR | hsa-miR-155-5p | Hodgkin disease | MNDR-E-MI-17840 |
| MNDR | hsa-miR-155-5p | Ulcerative colitis | MNDR-E-MI-17841 |
| MNDR | hsa-miR-155-5p | Burkitt lymphoma | MNDR-E-MI-17842 |
| MNDR | hsa-miR-155-5p | Mouth neoplasms | MNDR-E-MI-17843 |
| MNDR | hsa-miR-155-5p | Crohn disease | MNDR-E-MI-17844 |
| MNDR | hsa-miR-155-5p | Intermediate coronary syndrome | MNDR-E-MI-17845 |
| MNDR | hsa-miR-155-5p | Tonsil cancer | MNDR-E-MI-17846 |
| MNDR | hsa-miR-155-5p | Skin cutaneous melanoma | MNDR-E-MI-17847 |
| MNDR | hsa-miR-155-5p | Skin melanoma | MNDR-E-MI-17848 |
| MNDR | hsa-miR-155-5p | Subacute sclerosing panencephalitis | MNDR-E-MI-17849 |
| MNDR | hsa-miR-155-5p | Systemic lupus erythematosus | MNDR-E-MI-17850 |
| MNDR | hsa-miR-155-5p | Acute myelocytic leukemia | MNDR-E-MI-17851 |
| MNDR | hsa-miR-155-5p | Colorectal cancer | MNDR-E-MI-17852 |
| MNDR | hsa-miR-155-5p | Nasopharyngeal carcinoma | MNDR-E-MI-17853 |
| MNDR | hsa-miR-155-5p | Multiple myeloma | MNDR-E-MI-17854 |
| MNDR | hsa-miR-155-5p | Ovarian epithelial cancer | MNDR-E-MI-17855 |
| MNDR | hsa-miR-155-5p | Cardiomegaly | MNDR-E-MI-17856 |
| MNDR | hsa-miR-155-5p | Inflammation | MNDR-E-MI-17857 |
| MNDR | hsa-miR-155-5p | Nasopharyngeal cancer | MNDR-E-MI-17858 |
| MNDR | hsa-miR-155-5p | Wounds and injuries | MNDR-E-MI-17859 |
| MNDR | hsa-miR-155-5p | Polymyositis | MNDR-E-MI-17860 |
| MNDR | hsa-miR-155-5p | Epstein-barr virus infections | MNDR-E-MI-17861 |
| MNDR | hsa-miR-155-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-17862 |
| MNDR | hsa-miR-155-5p | Gait ataxia | MNDR-E-MI-17863 |
| MNDR | hsa-miR-155-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-17864 |
| MNDR | hsa-miR-155-5p | Lung injury | MNDR-E-MI-17865 |
| MNDR | hsa-miR-155-5p | Plaque atherosclerotic | MNDR-E-MI-17866 |
| MNDR | hsa-miR-155-5p | Breast cancer her3+ negative | MNDR-E-MI-17867 |
| MNDR | hsa-miR-155-5p | Tubulovillous adenoma | MNDR-E-MI-17868 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACTR2 | Homo sapiens | RR00038256 |
TOP